The role of PI3Kγ in the immune system: new insights and translational implications.
Stephen M LanahanMatthias P WymannCarrie L LucasPublished in: Nature reviews. Immunology (2022)
Over the past two decades, new insights have positioned phosphoinositide 3-kinase-γ (PI3Kγ) as a context-dependent modulator of immunity and inflammation. Recent advances in protein structure determination and drug development have allowed for generation of highly specific PI3Kγ inhibitors, with the first now in clinical trials for several oncology indications. Recently, a monogenic immune disorder caused by PI3Kγ deficiency was discovered in humans and modelled in mice. Human inactivated PI3Kγ syndrome confirms the immunomodulatory roles of PI3Kγ and strengthens newly defined roles of this molecule in modulating inflammatory cytokine release in macrophages. Here, we review the functions of PI3Kγ in the immune system and discuss how our understanding of its potential as a therapeutic target has evolved.
Keyphrases
- clinical trial
- oxidative stress
- endothelial cells
- palliative care
- induced pluripotent stem cells
- pluripotent stem cells
- case report
- high fat diet induced
- signaling pathway
- solid phase extraction
- protein kinase
- binding protein
- molecularly imprinted
- replacement therapy
- wild type
- mass spectrometry
- adipose tissue
- skeletal muscle
- small molecule
- double blind